Article

PDT may aid patients with minimally classic CNV

Study of verteporfin therapy leads to new VIM Trial to determine effectof fluence rate, light dose

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
Ocular or orbital trauma associated with increased risk of mortality in victims of intimate partner violence
September 17th 2025

Ocular or orbital trauma associated with increased risk of mortality in victims of intimate partner violence

3 Things You Should Know About the GA Pipeline
September 17th 2025

NK Insights: An Interactive Corneal Sensitivity Testing Workshop

(Image credit: AdobeStock/sky_diez) EyeCon 2025: A collaborative vision for the future of eye care
September 17th 2025

EyeCon 2025: Sun, sea, and a shared vision for the future of eye care

3 Things You Should Know About the GA Pipeline
September 17th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Kodiak announces new data from APEX study of KSI-101
September 17th 2025

Kodiak announces new data from APEX study of KSI-101

STAAR Surgical files definitive proxy statement on pending merger with Alcon
September 17th 2025

STAAR Surgical files definitive proxy statement on pending merger with Alcon

© 2025 MJH Life Sciences

All rights reserved.